Further analysis of the screening results revealed that Smurf2 is a potential novel target that synergizes with cisplatin chemotherapy and radiation to induce cytotoxicity in NSCLC cell lines. The gene discussed is SMURF2; the disease is non-small cell lung carcinoma.